139 related articles for article (PubMed ID: 37806191)
21. Vascular Analysis of Soft Tissues Around the Bone Lesion in Osteoradionecrosis, Medication-Related Osteonecrosis, and Infectious Osteomyelitis of the Jaw.
Wang Z; Xu J; Wan J; Zhang W; Wang Y; Du Y
J Craniofac Surg; 2022 Oct; 33(7):e750-e754. PubMed ID: 36201691
[TBL] [Abstract][Full Text] [Related]
22. Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study.
Stockmann P; Wehrhan F; Schwarz-Furlan S; Stelzle F; Trabert S; Neukam FW; Nkenke E
J Transl Med; 2011 Aug; 9():135. PubMed ID: 21843332
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review.
Almazrooa SA; Woo SB
J Am Dent Assoc; 2009 Jul; 140(7):864-75. PubMed ID: 19571050
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: a histological study on biopsies.
Wehrhan F; Hyckel P; Guentsch A; Nkenke E; Stockmann P; Schlegel KA; Neukam FW; Amann K
J Transl Med; 2011 Jul; 9():102. PubMed ID: 21726429
[TBL] [Abstract][Full Text] [Related]
25. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis.
Shuster A; Reiser V; Trejo L; Ianculovici C; Kleinman S; Kaplan I
Int J Oral Maxillofac Surg; 2019 Jan; 48(1):17-22. PubMed ID: 30054185
[TBL] [Abstract][Full Text] [Related]
27. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
[TBL] [Abstract][Full Text] [Related]
28. Radiographic signs of bisphosphonate-related osteonecrosis of the jaw.
Ganguly R; Ramesh A; Oreadi D
J Mass Dent Soc; 2012; 61(3):54-6. PubMed ID: 23311051
[No Abstract] [Full Text] [Related]
29. Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note.
Fleisher KE; Doty S; Kottal S; Phelan J; Norman RG; Glickman RS
J Oral Maxillofac Surg; 2008 Dec; 66(12):2646-53. PubMed ID: 19022151
[No Abstract] [Full Text] [Related]
30. [Osteomyelitis of the jaw in breast cancer patients receiving bisphosphonate therapy].
Tomihara K; Nagai I; Yamaguchi A; Miyazaki A; Dehari H; Abe M; Nakamori K; Komai K; Nakai M; Hiratsuka H
Gan To Kagaku Ryoho; 2008 Jan; 35(1):113-6. PubMed ID: 18195538
[TBL] [Abstract][Full Text] [Related]
31. Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study.
De Antoni CC; Matsumoto MA; Silva AAD; Curi MM; Santiago Júnior JF; Sassi LM; Cardoso CL
Braz Oral Res; 2018; 32():e23. PubMed ID: 29723337
[TBL] [Abstract][Full Text] [Related]
32. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
Ngoc Thuy Tran V; Chaisuparat R
J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
[TBL] [Abstract][Full Text] [Related]
33. Distinguishing features of the oral cavity and its predisposition to osteonecrosis.
McCauley LK; Li X
J Musculoskelet Neuronal Interact; 2007; 7(4):356-7. PubMed ID: 18094511
[No Abstract] [Full Text] [Related]
34. Radiographic characteristics of chronic diffuse sclerosing osteomyelitis/tendoperiostitis of the mandible: A comparison with chronic suppurative osteomyelitis and osteoradionecrosis.
van de Meent MM; Pichardo SEC; Rodrigues MF; Verbist BM; van Merkesteyn JPR
J Craniomaxillofac Surg; 2018 Sep; 46(9):1631-1636. PubMed ID: 30017711
[TBL] [Abstract][Full Text] [Related]
35. Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease.
McMahon RE; Bouquot JE; Glueck CJ; Griep JA; Adams WR; Spolnik KJ; Deardorf KA
J Oral Maxillofac Surg; 2007 Sep; 65(9):1899-900. PubMed ID: 17719423
[No Abstract] [Full Text] [Related]
36. Making a case for defining osteonecrosis of the jaw.
Van Poznak C
J Dent Res; 2011 Apr; 90(4):399-401. PubMed ID: 21317244
[No Abstract] [Full Text] [Related]
37. [Thoughts on the prevention, clinical diagnosis and treatment of osteonecrosis of the jaw and future research directions].
Guo CB
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 May; 56(5):401-403. PubMed ID: 33904271
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory Lesions of the Jaws.
Omami G; Wiggins RH
Dent Clin North Am; 2024 Apr; 68(2):259-276. PubMed ID: 38417990
[TBL] [Abstract][Full Text] [Related]
39. Introduction to osteonecrosis of the femoral head (OFH) and osteonecrosis of the jaw (ONJ).
Kim HK
J Musculoskelet Neuronal Interact; 2007; 7(4):350-3. PubMed ID: 18094509
[No Abstract] [Full Text] [Related]
40. Persisting alveolar sockets-a radiologic symptom of BP-ONJ?
Groetz KA; Al-Nawas B
J Oral Maxillofac Surg; 2006 Oct; 64(10):1571-2. PubMed ID: 16982320
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
